Cargando…
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
The management of patients scheduled for surgery with a coronary stent, and receiving 1 or more antiplatelet drugs, has many controversies. The premature discontinuation of antiplatelet drugs substantially increases the risk of stent thrombosis (ST), myocardial infarction, and cardiac death, and sur...
Autores principales: | Llau, Juan V, Ferrandis, Raquel, Sierra, Pilar, Gómez-Luque, Aurelio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952454/ https://www.ncbi.nlm.nih.gov/pubmed/20957131 http://dx.doi.org/10.2147/VHRM.S7402 |
Ejemplares similares
-
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
por: Ferrandis, Raquel, et al.
Publicado: (2021) -
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020) -
Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery
por: Ferrandis, Raquel, et al.
Publicado: (2009) -
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008) -
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)